Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
12/2003
12/04/2003US20030225276 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225081 Pyridazinones and triazinones and medicinal use thereof
12/04/2003US20030224941 Uracil substituted phenyl sulfamoyl carboxamides
12/04/2003US20030224300 Photographic processing composition containing heterocycle combination and method of forming image
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003CN1129590C Reference compound for use in analysis of levosimendan batches
11/2003
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097613A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003WO2003097612A1 Substituted 2-phenyl-3(2h)-pyridazinones
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
11/27/2003US20030220498 Use of toxicologically benign iron salts or iron complexes as the catalysts, and commercially attractive aryl chlorides as well as various aryl sulfonates and aryl phosphonates can be used as starting materials
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/27/2003US20030220320 Ningalin b analogs employable for reversing multidrug resistance
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2485896A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003CA2482151A1 Substituted 2-phenyl-3(2h)-pyridazinones
11/26/2003EP1144380A4 A meta-nitro phenol derivative and a process for producing it
11/26/2003CN1458924A Pyridazinones and triazinones and medicinal use thereof
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362034A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/13/2003WO2003093261A1 Phthalazinone derivatives
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003US20030212272 Vasodilation; hypotensive agents; cardiovascular disorders
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2482806A1 Phthalazinone derivatives
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003CN1127487C Phthalazinone and its use, and drug containing same
11/12/2003CN1127486C Phthalazine derivatives phosphodiesterase 4 inhibitors
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003CA2133579C Synergistic composition and process for selective weed control
11/06/2003US20030207882 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1087956B1 A reference compound for use in the analysis of levosimendan batches
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003US20030203902 A 2-hydroxy-2-trifluoromethyl-valeroylamino benzotriazole, or benzo(1,2,5)thiadiazole, or benzo(1,2,5)oxadiazole derivatives; contraceptive agents, for treating endometriosis, gynecological disorders, male birth control
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/23/2003WO2003087067A1 Aryl-alkyne compounds as herbicides
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003US20030199513 Cinnoline derivatives and use as medicine
10/23/2003US20030199512 Such as 1-hydrazinophthalazine; metal-free
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030198608 Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external prepraration for skin
10/23/2003CA2481008A1 Aryl-alkyne compounds as herbicides
10/22/2003EP1353911A1 Antiviral agents
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1265873B1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003CN1124267C Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
10/15/2003CN1124259C Benzylsulfide derivative, process for its production and pesticide
10/14/2003US6632942 3S)-piperazic acid is derived from D-glutamic acid through an (R)-2,5-dihydroxyvalerate ester intermediate. After the hydroxy groups are converted to suitable leaving groups, such as mesylates, the ester is treated with a bis-protected
10/14/2003US6632919 Bind Watson-Crick base pairs in a double helix; specific for thymidine
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003US20030187259 Heterocylic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/01/2003EP1348698A1 Substituted carboxylic acid derivatives
09/2003
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003039451A3 Thiazole pyridazinones as adenosine antagonists
09/25/2003US20030181455 Bicyclic and tricyclic hetroaromatic compounds
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 85